Which Factors Will Push The In-vitro Colorectal Cancer Screening Tests Market To Achieve $1.71 Billion By 2029?
Uncover key drivers, emerging technologies, and competitive movements shaping the in-vitro colorectal cancer screening tests market from 2025–2034 with trusted insights from The Business Research Company
What Is The Projected Valuation Of The In-vitro Colorectal Cancer Screening Tests Market In The Coming Years?
The in-vitro colorectal cancer screening tests market size has seen substantial growth recently. It is anticipated to expand from $1.21 billion in 2024 to $1.30 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.4%. The increase observed in previous periods is largely due to greater awareness of early cancer detection, the proliferation of government screening programs, the growing preference for non-invasive testing methods, rising healthcare expenditure, and the wider accessibility of at-home screening kits.
The market for in-vitro colorectal cancer screening tests is projected to experience robust expansion in the coming years. This market is set to reach $1.71 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.0%. Key drivers for this growth during the forecast period include a heightened emphasis on personalized medicine, a growing need for affordable diagnostics, increased funding for cancer research, greater adoption of molecular diagnostic methods, the rising incidence of colorectal cancer, and improved access to testing in developing regions. Significant trends anticipated in the forecast period encompass progress in liquid biopsy technologies, novel approaches in biomarker identification, the incorporation of artificial intelligence into test analysis, sophisticated development of multi-target stool deoxyribonucleic acid tests, advancements in sample collection and processing, improvements in automation and digital pathology, and the implementation of cloud-based diagnostic platforms.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27319&type=smp
Which Growth Drivers Are Shaping The In-vitro Colorectal Cancer Screening Tests Market Outlook?
The escalating occurrence of colorectal cancer is anticipated to fuel the expansion of the in vitro colorectal cancer screening tests market moving forward. Colorectal cancer, originating in the colon or rectum often from precancerous polyps, is seeing an increased prevalence primarily due to unhealthy lifestyle choices such as poor diet, lack of exercise, and obesity, which heighten the risk of polyp formation and subsequent cancer development. In vitro colorectal cancer screening tests are crucial for diagnosis, providing non-invasive methods for early cancer detection and improving screening accuracy through advanced biomarker identification, thereby enhancing early intervention and patient prognosis. For illustration, the American Cancer Society, a US-based nonprofit organization, estimated 154,270 new colorectal cancer cases in February 2025, marking an increase from 152,810 cases in 2024. Consequently, the rising incidence of colorectal cancer is a significant driver for the growth of the in vitro colorectal cancer screening tests market.
What Is The Segment Breakdown Of The In-vitro Colorectal Cancer Screening Tests Market?
The in-vitro colorectal cancer screening tests market covered in this report is segmented
1) By Test Type: Fecal Occult Blood Test, Stool Deoxyribonucleic Acid Test, Blood Biomarker Test, Other Test Types
2) By Imaging Type: Colonoscopy, Proctoscopy, Computed Tomography Scan, Ultrasound, Magnetic Resonance Imaging, Positron Emission Tomography Scan
3) By Application: Screening, Diagnosis, Monitoring, Risk Assessment, Post-Treatment Surveillance
4) By End User: Hospitals, Diagnostic Laboratories, Outpatient Clinics, Home Care Settings, Research Institutions
Subsegments:
1) By Fecal Occult Blood Test: Guaiac Based Fecal Occult Blood Test, Immunochemical Fecal Occult Blood Test
2) By Stool Deoxyribonucleic Acid Test: Single Target Stool Deoxyribonucleic Acid Test, Multi Target Stool Deoxyribonucleic Acid Test
3) By Blood Biomarker Test: Methylated Septin 9 Deoxyribonucleic Acid Test, Circulating Tumor Deoxyribonucleic Acid Test, Protein Biomarker Based Blood Test
4) By Other Test Types: Urine Based Biomarker Test, Serum Based Biomarker Test, Breath Based Volatile Organic Compound Test
How Are Global Trends Impacting The Development Of The In-vitro Colorectal Cancer Screening Tests Market?
Leading companies active in the in vitro colorectal cancer screening tests market are concentrating on creating advanced diagnostic methods, such as multi-target stool DNA tests, to enhance the precision of early detection, improve patient ease, and decrease colorectal cancer mortality rates. Multi-target stool DNA tests are innovative screening instruments that scrutinize stool samples for genetic and biochemical indicators related to colorectal cancer and precancerous lesions. For example, in March 2025, Exact Sciences Corp., a US-based molecular diagnostics company, unveiled Cologuard Plus, an upgraded at-home colorectal cancer screening test for average-risk adults aged 45 and older. This test integrates advanced biomarker technology, delivering increased sensitivity and specificity compared to its previous iteration. It employs a refined algorithm to identify DNA mutations and hemoglobin biomarkers, thereby improving the detection of both colorectal cancer and advanced adenomas. The Cologuard Plus test provides a non-invasive and convenient screening choice that eliminates the necessity for bowel preparation or dietary restrictions, consequently boosting patient adherence to recommended screening guidelines.
Who Are The Major Stakeholders Operating In The In-vitro Colorectal Cancer Screening Tests Market?
Major companies operating in the in-vitro colorectal cancer screening tests market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Quest Diagnostics Incorporated, Roche Diagnostics International AG, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Natera Inc., Leica Biosystems Nussloch GmbH, BGI Genomics Co. Ltd., NeoGenomics Inc., Guardant Health Inc., CellMax Life Inc., Epigenomics AG, Acuamark Diagnostics Inc., Beacon Biomedical Inc., Mainz Biomed NV.
Access The Complete Report Here:
Which Region Is Likely To Register The Fastest Growth In The In-vitro Colorectal Cancer Screening Tests Market?
North America was the largest region in the in-vitro colorectal cancer screening tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro colorectal cancer screening tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=27319&type=smp
Browse Through More Reports Similar to the Global In-vitro Colorectal Cancer Screening Tests Market 2025, By The Business Research Company
Buildings Construction Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/buildings-construction-global-market-report
Construction Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/construction-global-market-report
Transportation Infrastructure Construction Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
